Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8441996 | European Journal of Cancer | 2015 | 7 Pages |
Abstract
Consistent with the findings of recent randomised trials, our long-term data indicate that most elderly, ER-positive patients with pT1 cN0 breast cancer treated by quadrantectomy do not benefit from RT. The 14.6% CCI of IBTR in our pT2 patients is an additional finding not presented in the trials and suggests that RT should be administered to elderly patients with pT2 disease.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Gabriele Martelli, Patrizia Boracchi, Eleonora Guzzetti, Giuseppe Marano, Laura Lozza, Roberto Agresti, Cristina Ferraris, Domenico Piromalli, Marco Greco,